| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | single-stranded DNA 3'-5' DNA exonuclease activity | 4.20e-05 | 6 | 34 | 2 | GO:0008310 | |
| GeneOntologyMolecularFunction | single-stranded DNA exodeoxyribonuclease activity | 1.26e-04 | 10 | 34 | 2 | GO:0008297 | |
| GeneOntologyMolecularFunction | 3'-5'-DNA exonuclease activity | 3.33e-04 | 16 | 34 | 2 | GO:0008296 | |
| GeneOntologyMolecularFunction | DNA exonuclease activity, producing 5'-phosphomonoesters | 8.24e-04 | 25 | 34 | 2 | GO:0016895 | |
| GeneOntologyMolecularFunction | DNA exonuclease activity | 8.91e-04 | 26 | 34 | 2 | GO:0004529 | |
| GeneOntologyMolecularFunction | MAP kinase kinase kinase activity | 9.62e-04 | 27 | 34 | 2 | GO:0004709 | |
| GeneOntologyBiologicalProcess | regulation of anion channel activity | 3.71e-05 | 6 | 33 | 2 | GO:0010359 | |
| GeneOntologyBiologicalProcess | regulation of monoatomic anion transmembrane transport | 6.91e-05 | 8 | 33 | 2 | GO:1903959 | |
| GeneOntologyBiologicalProcess | dermatan sulfate metabolic process | 1.11e-04 | 10 | 33 | 2 | GO:0030205 | |
| GeneOntologyBiologicalProcess | dermatan sulfate proteoglycan metabolic process | 1.91e-04 | 13 | 33 | 2 | GO:0050655 | |
| HumanPheno | Childhood onset | 3.85e-05 | 938 | 6 | 6 | HP:0011463 | |
| Domain | Peptidase_M60_dom | 3.03e-06 | 2 | 33 | 2 | IPR031161 | |
| Domain | M60-like | 3.03e-06 | 2 | 33 | 2 | SM01276 | |
| Domain | Peptidase_M60 | 3.03e-06 | 2 | 33 | 2 | PF13402 | |
| Domain | PEPTIDASE_M60 | 3.03e-06 | 2 | 33 | 2 | PS51723 | |
| Domain | Class_I_gatase-like | 1.98e-04 | 12 | 33 | 2 | IPR029062 | |
| Domain | Prot_kinase_dom | 1.04e-02 | 489 | 33 | 4 | IPR000719 | |
| Domain | PROTEIN_KINASE_DOM | 1.07e-02 | 493 | 33 | 4 | PS50011 | |
| Domain | Kinase-like_dom | 1.47e-02 | 542 | 33 | 4 | IPR011009 | |
| Pubmed | 9.28e-07 | 2 | 34 | 2 | 34433829 | ||
| Pubmed | 5.56e-06 | 4 | 34 | 2 | 25559186 | ||
| Pubmed | MAP3Ks as central regulators of cell fate during development. | 9.66e-05 | 15 | 34 | 2 | 18855897 | |
| Pubmed | 1.10e-04 | 16 | 34 | 2 | 17903297 | ||
| Pubmed | 1.74e-04 | 20 | 34 | 2 | 19668339 | ||
| Pubmed | Functional analysis of secreted and transmembrane proteins critical to mouse development. | 4.24e-04 | 31 | 34 | 2 | 11431694 | |
| Cytoband | 7q35 | 7.71e-04 | 55 | 34 | 2 | 7q35 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr7q35 | 1.11e-03 | 66 | 34 | 2 | chr7q35 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr11q12 | 2.12e-03 | 345 | 34 | 3 | chr11q12 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr5q14 | 4.59e-03 | 136 | 34 | 2 | chr5q14 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr9q33 | 4.72e-03 | 138 | 34 | 2 | chr9q33 | |
| Cytoband | 11q12.1 | 6.37e-03 | 161 | 34 | 2 | 11q12.1 | |
| GeneFamily | Mitogen-activated protein kinase kinase kinases|RAF family | 4.58e-04 | 24 | 24 | 2 | 654 | |
| ToppCell | URO-Lymphocyte-T_NK-CD8_TCM|URO / Disease, Lineage and Cell Type | 7.28e-08 | 141 | 34 | 5 | 53aef819f505238011f8a3202445f31055791d05 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Immune-Myeloid-Granulocytic-Mast_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.78e-06 | 167 | 34 | 4 | a813b95c2fafb638b249bc4fa4f708c6f39ad444 | |
| ToppCell | ASK452-Immune-Mast_cell|ASK452 / Donor, Lineage and Cell class of Lung cells from Dropseq | 1.24e-05 | 188 | 34 | 4 | 840215e16cff90f821f776186284eafcf2350690 | |
| ToppCell | LPS_only-Hematopoietic_Mast-Mast_cells-Mast-cells|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.51e-04 | 136 | 34 | 3 | 82d7f90ef2a63a3137c331efd68c036cd0db3ac1 | |
| ToppCell | Influenza_Severe-Treg|World / Disease group and Cell class | 1.98e-04 | 149 | 34 | 3 | 3250bb668319139451c31aa496b3ca1ed6750ce4 | |
| ToppCell | Bac-SEP-Lymphocyte-T_NK-MAIT|Bac-SEP / Disease, Lineage and Cell Type | 2.39e-04 | 159 | 34 | 3 | e043c65f3febdfa7f75a67702e92fcdebe144a00 | |
| ToppCell | droplet-Fat-SCAT-30m-Hematologic-nan|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.44e-04 | 160 | 34 | 3 | 67ee7a314d7d4d3ea206e0158083f36f6dd7e80b | |
| ToppCell | droplet-Fat-SCAT-30m-Hematologic-erythroblast|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.44e-04 | 160 | 34 | 3 | fc76337ad766c859db390ef8b6fb9caeaace3a56 | |
| ToppCell | droplet-Fat-SCAT-30m-Hematologic|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.44e-04 | 160 | 34 | 3 | 759749f708c3a2b36692d42499f19aff937e592f | |
| ToppCell | BL-critical-LOC-Myeloid-Basophil|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.53e-04 | 162 | 34 | 3 | 25ec9df914445b4daae4fd28fd0e60b64797c46d | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_2-AT1_Progenitor|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.57e-04 | 163 | 34 | 3 | fd35f1237c23367753ac2bc3e893f0e3c714129c | |
| ToppCell | 367C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_3|CD8+_Cytotoxic_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 2.62e-04 | 164 | 34 | 3 | d2218d50e0e2d19f919dcb460b3840687c082810 | |
| ToppCell | remission-HSPC|World / disease stage, cell group and cell class | 2.71e-04 | 166 | 34 | 3 | d269ee6f7adb55b05dcb5eaea96629ccb0b2d6e3 | |
| ToppCell | tumor_Lymph_Node_/_Brain-T/NK_cells-CD8+/CD4+_Mixed_Th|tumor_Lymph_Node_/_Brain / Location, Cell class and cell subclass | 2.76e-04 | 167 | 34 | 3 | c0c944eae0514dc8e00d0c2892a0792e157695ec | |
| ToppCell | facs-Lung-EPCAM-3m-Lymphocytic-B_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.81e-04 | 168 | 34 | 3 | 784ce773521e5d74570f45120e56d112bc76ff49 | |
| ToppCell | COVID-19_Convalescent-Hematopoietic_SC|COVID-19_Convalescent / Disease group, lineage and cell class | 2.91e-04 | 170 | 34 | 3 | 8a73d5334eed1cd9fdcc3ebeae0bdf9f945c228a | |
| ToppCell | facs-Lung-EPCAM-3m-Lymphocytic-B_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.91e-04 | 170 | 34 | 3 | 7a4ed69c807c3761210776e8fe6680d1bd892e82 | |
| ToppCell | PBMC-Convalescent-Hematopoietic-HSPC|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.96e-04 | 171 | 34 | 3 | 172db31a37b72fb87fe5f0f79da51866b90dd1ad | |
| ToppCell | wk_20-22-Hematologic-Myeloid-Eosinophil|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 2.96e-04 | 171 | 34 | 3 | fa6e856e62b82ec4972e0098e73f237cc611891f | |
| ToppCell | 368C-Myeloid-Dendritic-pDC|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 2.96e-04 | 171 | 34 | 3 | 714a0b0d0c9886fef64170cf53eb64f0d8a47280 | |
| ToppCell | PBMC-Convalescent-Hematopoietic-HSPC-HSPC|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.96e-04 | 171 | 34 | 3 | 2031797d579ce373921affad70da6e50eec13664 | |
| ToppCell | remission-HSPC|remission / disease stage, cell group and cell class | 2.96e-04 | 171 | 34 | 3 | 41b424e58470a2fc25632aea50a37c7c5ea17645 | |
| ToppCell | PBMC-Convalescent-Hematopoietic-HSPC-HSPC-|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.96e-04 | 171 | 34 | 3 | a4e13b304ef414722ffdc06560deeab41785e956 | |
| ToppCell | 368C-Myeloid-Dendritic-pDC|Dendritic / Donor, Lineage, Cell class and subclass (all cells) | 2.96e-04 | 171 | 34 | 3 | f3bf5805823d5733b58742172e7668725ce82931 | |
| ToppCell | PBMC-Convalescent-Hematopoietic-HSPC-HSPC-|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 3.01e-04 | 172 | 34 | 3 | 8fd3db757d54949bd583d5f0eadf63a32342cb9d | |
| ToppCell | PBMC-Convalescent-Hematopoietic-HSPC-HSPC|Convalescent / Location, Disease Group, Cell group, Cell class (2021.03.09) | 3.01e-04 | 172 | 34 | 3 | 382cb5fea099110eb026a8bba6cf4c28763ea52f | |
| ToppCell | PBMC-Convalescent-Hematopoietic-HSPC|Convalescent / Location, Disease Group, Cell group, Cell class (2021.03.09) | 3.01e-04 | 172 | 34 | 3 | da78f7a71b7f05c5c484c9ed19ba37c55d35e870 | |
| ToppCell | 10x5'-blood-Mast-Mast_cells|blood / Manually curated celltypes from each tissue | 3.11e-04 | 174 | 34 | 3 | a5838821bba2be790d32331ff529d466e9974268 | |
| ToppCell | 10x5'-blood-Lymphocytic_T_CD8-Tnaive/CM_CD8|blood / Manually curated celltypes from each tissue | 3.11e-04 | 174 | 34 | 3 | 8273de40552d1cca1a8fe3647fd5e4cb4bb70f99 | |
| ToppCell | 10x5'-blood-Mast|blood / Manually curated celltypes from each tissue | 3.11e-04 | 174 | 34 | 3 | 3a8a253213b207e3ff56f94a74996b8d9ad47aa1 | |
| ToppCell | mild-Myeloid-pDC|Myeloid / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 3.22e-04 | 176 | 34 | 3 | 59a9c262c252b7d220a025837922d98e9d6b0a24 | |
| ToppCell | 3'_v3-lymph-node_spleen-Mast-Mast_cell_lympho|lymph-node_spleen / Manually curated celltypes from each tissue | 3.27e-04 | 177 | 34 | 3 | 53040dbeb18574a48e352e4bce252c7c3018762c | |
| ToppCell | LAM-Myeloid-Mast|Myeloid / Condition, Lineage and Cell class | 3.33e-04 | 178 | 34 | 3 | 19cb1a46ba2f5c19180b6b0586acfaf075afff1c | |
| ToppCell | 343B-Lymphocytic-CD4_T-cell-Treg_cell_4|343B / Donor, Lineage, Cell class and subclass (all cells) | 3.38e-04 | 179 | 34 | 3 | c09c3eed43d1aa3b7aa8f3021e6f2737840cde16 | |
| ToppCell | mild-Myeloid-pDC|mild / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 3.44e-04 | 180 | 34 | 3 | 38614155fa537d0defda914c531c697be0ef06d8 | |
| ToppCell | 18-Airway-Immune-Hematopoietic,_B_Cells|Airway / Age, Tissue, Lineage and Cell class | 3.44e-04 | 180 | 34 | 3 | 200cecbd8c12a4ec334583fdd5057397504de71e | |
| ToppCell | COVID-19_Convalescent-Lymphoid_T/NK-CD8+_T_naive|COVID-19_Convalescent / Disease group, lineage and cell class | 3.67e-04 | 184 | 34 | 3 | 0299cd30a3ea8e861a9d529043c204048ae21d29 | |
| ToppCell | remission-CD8+_T_naive|remission / disease stage, cell group and cell class | 3.67e-04 | 184 | 34 | 3 | fe20fa4457d4a4a75689978275b0afb5f6243faf | |
| ToppCell | PBMC-Convalescent-Lymphocyte-T/NK-CD8+_T-CD8+_T_naive|Convalescent / Location, Disease Group, Cell group, Cell class (2021.03.09) | 3.73e-04 | 185 | 34 | 3 | 863a3d44c1f115942d7a2a2b63a92fe5fc768814 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.73e-04 | 185 | 34 | 3 | 6712512100ccef456d2e2bd201d0987986c92ac9 | |
| ToppCell | COVID-19_Convalescent-CD8+_T_naive|COVID-19_Convalescent / Disease condition and Cell class | 3.73e-04 | 185 | 34 | 3 | 2f8277a0b58fb0c49fa76ff6dfa6da961da1f9f5 | |
| ToppCell | remission-CD8+_T_naive|World / disease stage, cell group and cell class | 3.73e-04 | 185 | 34 | 3 | 69304d7dd406ac7e96d51c239d7035a06d88704f | |
| ToppCell | PBMC-Convalescent-Lymphocyte-T/NK-CD8+_T-CD8+_T_naive|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.73e-04 | 185 | 34 | 3 | 27dbfcd40ec832d5cf757331d8af3b5176ae90fb | |
| ToppCell | PBMC-Convalescent-Lymphocyte-T/NK-CD8+_T-CD8+_T_naive-|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 3.73e-04 | 185 | 34 | 3 | 1c23891e4d75f99296d1304af7a9d6c3cb28d04c | |
| ToppCell | PBMC-Convalescent-Lymphocyte-T/NK-CD8+_T-CD8+_T_naive-|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.73e-04 | 185 | 34 | 3 | ca8e921a6b45cd39474b9f86c95e7be023585c5d | |
| ToppCell | Primary_Visual_cortex_(V1C)-Non-neuronal-Macroglial-Astro-Astrocyte-Astro_L1-6_FGFR3_ETNPPL|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.79e-04 | 186 | 34 | 3 | 73cf266aeecd3cc15e8cb6094588a393bca8fbe6 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Non-neuronal-Macroglial-Astro-Astrocyte-Astro_L1_FGFR3_MT1G|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.85e-04 | 187 | 34 | 3 | 2b1b2c3792d6c9ab69675ce88842bb589414b530 | |
| ToppCell | droplet-Marrow-nan-21m-Lymphocytic-nan|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.91e-04 | 188 | 34 | 3 | 7e27e49ec1eb02fb74c86ec2ccb84751bc778b21 | |
| ToppCell | droplet-Marrow-nan-21m-Lymphocytic|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.91e-04 | 188 | 34 | 3 | 4b14c3ad80507245564d5be96d33fd9361f67dd0 | |
| ToppCell | facs-Marrow-T-cells-3m-Lymphocytic-naive_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.91e-04 | 188 | 34 | 3 | 1f07e3ab87173426fe0c429f5c084fb3425effd3 | |
| ToppCell | droplet-Tongue-nan-24m-Epithelial-suprabasal_differentiating|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.91e-04 | 188 | 34 | 3 | b40146ed0af022422e6526116e5897c676ed9d71 | |
| ToppCell | facs-Marrow-T-cells-3m-Lymphocytic-naive_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.91e-04 | 188 | 34 | 3 | 85746f95319e494efdc1bbc24331698688d3a900 | |
| ToppCell | tumor_Lung-MAST_cells-MAST|tumor_Lung / Location, Cell class and cell subclass | 3.97e-04 | 189 | 34 | 3 | cd977962e01756b663728dae32ab9aba15bf7e22 | |
| ToppCell | tumor_Lung-MAST_cells|tumor_Lung / Location, Cell class and cell subclass | 3.97e-04 | 189 | 34 | 3 | 300670be76454f197bd04f82c533579dd3671969 | |
| ToppCell | facs-BAT-Fat-3m|BAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.97e-04 | 189 | 34 | 3 | 7ce71f9c81512ed38c804f025908746b4af3aab1 | |
| ToppCell | 3'-Parenchyma_lung-Immune_Myeloid_mast-Myeloid_Mast/Baso-mast_cell-Mast_cells-Mast_cells_L.1.4.1.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.97e-04 | 189 | 34 | 3 | d26af19fd7e0c7eb78a5a3a245ca5229c4e9e847 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Non-neuronal-Macroglial-Astro|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.03e-04 | 190 | 34 | 3 | 78cc6c28b31de041c24175a98f47da256ecc15a2 | |
| ToppCell | droplet-Marrow-nan-18m-Lymphocytic|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.03e-04 | 190 | 34 | 3 | 240923769fef18eaf73d2efa3d5f745f5533b0ce | |
| ToppCell | Primary_Visual_cortex_(V1C)-Non-neuronal-Macroglial-Astro-Astrocyte|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.03e-04 | 190 | 34 | 3 | e67d9400467b438592690b23d681e6c2fb8f09fd | |
| ToppCell | Control-Endothelial-VE_Venous|Endothelial / Disease state, Lineage and Cell class | 4.03e-04 | 190 | 34 | 3 | 4e30155203b4a8c5e496fcbe9348b67b98ebc625 | |
| ToppCell | droplet-Marrow-nan-18m-Lymphocytic-nan|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.03e-04 | 190 | 34 | 3 | 9df9b9e91c97e504c189d6055a6aabc54ad17cec | |
| ToppCell | control-Myeloid-Mast_cell|Myeloid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 4.09e-04 | 191 | 34 | 3 | afebdc59a1f884ce3f2f5fe040e16b0e95e4e7c5 | |
| ToppCell | COVID-19-Heart-EC_(POSTN)|Heart / Disease (COVID-19 only), tissue and cell type | 4.15e-04 | 192 | 34 | 3 | c0c34785a7bdf461722029b322e9184e3d9b3c26 | |
| ToppCell | 390C-Myeloid-Mast_cell|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 4.15e-04 | 192 | 34 | 3 | 201d430af1e4fee7bc03baf0aca17db26f6f439a | |
| ToppCell | 3'-Parenchyma_lung-Immune_Myeloid_mast-Myeloid_Mast/Baso-mast_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.15e-04 | 192 | 34 | 3 | 60a02e0ccdc8c7af9bc875b248467304fe0d24a4 | |
| ToppCell | ASK454-Immune-Mast_cell|Immune / Donor, Lineage and Cell class of Lung cells from Dropseq | 4.15e-04 | 192 | 34 | 3 | 01e6324146ea34785b770231b40f7a18f128f526 | |
| ToppCell | 3'-Parenchyma_lung-Immune_Myeloid_mast|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.15e-04 | 192 | 34 | 3 | 5532ea1bc012eb9303197b87e90bc39619b5ee2a | |
| ToppCell | 3'-Parenchyma_lung-Immune_Myeloid_mast-Myeloid_Mast/Baso-mast_cell-Mast_cells|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.15e-04 | 192 | 34 | 3 | b223fca73e16668f69a78cf4457e349d01792540 | |
| ToppCell | 390C-Myeloid-Mast_cell-|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 4.15e-04 | 192 | 34 | 3 | 15c1a0a0d07106118427135f166a1da710bf621a | |
| ToppCell | ASK454-Immune-Mast_cell|ASK454 / Donor, Lineage and Cell class of Lung cells from Dropseq | 4.15e-04 | 192 | 34 | 3 | 4ab2524cce70b6a3a3dd31085b421565a7406c56 | |
| ToppCell | 3'-Parenchyma_lung-Immune_Myeloid_mast-Myeloid_Mast/Baso|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.15e-04 | 192 | 34 | 3 | b5615a780b0ba24a8e554fac9238d3f0bcba52bc | |
| ToppCell | TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-6|TCGA-Prostate / Sample_Type by Project: Shred V9 | 4.22e-04 | 193 | 34 | 3 | abd71b2cf667ef2b1c4d88acd0c1dd19a12ff659 | |
| ToppCell | 3'-Parenchyma_lung-Immune_Myeloid_mast-Myeloid_Mast/Baso-mast_cell-Mast_cells-Mast_cells_L.1.4.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.22e-04 | 193 | 34 | 3 | c17e87c042ef095ac99fdd6facf3bc2886924dc4 | |
| ToppCell | distal-Hematologic-Basophil/Mast_1-1|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 4.35e-04 | 195 | 34 | 3 | a2623f4247c356cf92a0b6f9e454d67edde536ae | |
| ToppCell | 10x3'2.3-week_12-13-Myeloid_neutrophil-granulo-eo/baso/mast|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 4.41e-04 | 196 | 34 | 3 | ef481eb306350311207f7a29fdfa1ae3feaba4d7 | |
| ToppCell | COVID-19-kidney-TAL|kidney / Disease (COVID-19 only), tissue and cell type | 4.41e-04 | 196 | 34 | 3 | 04f5eb206ed3016a737609a3ebac0c1fcabb94ef | |
| ToppCell | 3'_v3-lymph-node_spleen-Lymphocytic_T_CD8-Tnaive/CM_CD8|lymph-node_spleen / Manually curated celltypes from each tissue | 4.41e-04 | 196 | 34 | 3 | e7fd508cb9a8a5b3d1c0247dabf486c4434b5e94 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Mesenchymal-immature_mesenchymal_cell|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.41e-04 | 196 | 34 | 3 | cbfe01ba8071864e19b37028236ae35789f630fe | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-Mast-Mast-Z|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 4.48e-04 | 197 | 34 | 3 | 7619924615a43011b4a86efbe6e7e5445f96722b | |
| ToppCell | COVID-19-COVID-19_Convalescent-Others-HSPC|COVID-19_Convalescent / Disease, condition lineage and cell class | 4.48e-04 | 197 | 34 | 3 | c1033a1a8b8b5c8569130aa9405a6e8e65ef7bd0 | |
| ToppCell | distal-1-Hematologic-Basophil/Mast_1|1 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 4.48e-04 | 197 | 34 | 3 | e33752427eefeacbbc538e1b35f37194bdabfc40 | |
| ToppCell | (2)_NK/T-(221)_CD8+_Naive_T_cell|(2)_NK/T / immune cells in Peripheral Blood (logTPM normalization) | 4.48e-04 | 197 | 34 | 3 | 5943f30288d4c9a7d7ef2e85461487a229f44511 | |
| ToppCell | Parenchymal-NucSeq-Immune_Myeloid-Macrophage_other-Macro_AW_CX3CR1|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.54e-04 | 198 | 34 | 3 | 732a43061d75bc5e1cf23f5056b72cd10c926668 | |
| ToppCell | Sepsis-Int-URO-Myeloid-pDC|Int-URO / Disease, condition lineage and cell class | 4.61e-04 | 199 | 34 | 3 | a41c3c3360b1b4546c9b2c49bda595feef6a4a4a | |
| ToppCell | LPS_anti-TNF-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 4.61e-04 | 199 | 34 | 3 | 38cfd367ee8c074c11ba54edeb7a001e375e2687 | |
| ToppCell | mLN-(7)_Mast_cell-(70)_Mast|mLN / shred on region, Cell_type, and subtype | 4.68e-04 | 200 | 34 | 3 | a6c258cae678be581b1d85cf3446c65c34b13499 | |
| ToppCell | mLN-Mast_cell-Mast|mLN / Region, Cell class and subclass | 4.68e-04 | 200 | 34 | 3 | 81ea6e7a3940277751faf9097b30198159998c7b | |
| ToppCell | COVID-19-COVID-19_Convalescent-Lymphocyte-T/NK-CD8+_T_naive|COVID-19_Convalescent / Disease, condition lineage and cell class | 4.68e-04 | 200 | 34 | 3 | 65ae349fac4084faacbc6a645a92398f6324770e | |
| ToppCell | MS-IIF-Lymphocyte-T/NK-ILC|IIF / Disease, condition lineage and cell class | 4.68e-04 | 200 | 34 | 3 | edb0b252e6ff9824908d1ff7d0d42710b00949c8 | |
| ToppCell | mLN-Mast_cell|mLN / Region, Cell class and subclass | 4.68e-04 | 200 | 34 | 3 | 9a5f1d99d8d160923d4d0fbbf9ad48a26f8a4fad | |
| ToppCell | mLN-(7)_Mast_cell|mLN / shred on region, Cell_type, and subtype | 4.68e-04 | 200 | 34 | 3 | 13bca944fbdbc0be6687eca82c62a4d231ab94f0 | |
| ToppCell | (22)_B_cell_memory|World / shred on Cell_type and subtype | 4.88e-04 | 203 | 34 | 3 | 94ac418c9bfef1ce2e000a9c4117485651dfe85a | |
| Disease | sleep quality | 2.34e-04 | 118 | 30 | 3 | EFO_0005272 | |
| Disease | neuropsychological test | 1.04e-03 | 197 | 30 | 3 | EFO_0003926 | |
| Disease | Bipolar Disorder | 1.32e-03 | 477 | 30 | 4 | C0005586 | |
| Disease | hippocampal atrophy | 1.49e-03 | 56 | 30 | 2 | EFO_0005039 | |
| Disease | opioid dependence | 1.77e-03 | 237 | 30 | 3 | EFO_0005611 | |
| Disease | age at menopause | 3.51e-03 | 302 | 30 | 3 | EFO_0004704 | |
| Disease | colorectal cancer, hormone replacement therapy | 3.62e-03 | 88 | 30 | 2 | EFO_0003961, MONDO_0005575 | |
| Disease | depressive symptom measurement, response to antidepressant | 3.62e-03 | 88 | 30 | 2 | EFO_0007006, GO_0036276 | |
| Disease | hearing impairment | 4.47e-03 | 98 | 30 | 2 | C1384666 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| HVHPNYFSLLMGWMG | 3551 | Q9NR09 | |
| SNGNHIFWPMGHSGM | 856 | Q5SY80 | |
| WGGLHMAYRHFWMLV | 6121 | Q8WXG9 | |
| IPFDHMMYEHLQKWG | 56 | Q96KQ4 | |
| SFLLHFWQGMPPHML | 226 | Q33E94 | |
| HYMAYWMGHREPQGV | 321 | Q9H790 | |
| PFMGAASMIHRFWEH | 256 | Q8NH63 | |
| KMYPRGNHWAVGHLM | 36 | P07492 | |
| HFAGMHGCTAFGWMT | 906 | P54098 | |
| IAMEFNHLYHWHPLM | 376 | P23219 | |
| EPWCHLLYGHMSYIM | 211 | A1L453 | |
| AGYALMAGAHGLWML | 121 | Q9UGQ3 | |
| GHMFMYFLRGSLPWQ | 236 | Q9Y6M4 | |
| FWYPGATHHVAANMM | 51 | P15088 | |
| WSMGIAGGMNYLHLH | 216 | Q12852 | |
| PFMIHQLMGNGVWHF | 166 | Q99705 | |
| AGYTTHMVGKWHLGM | 136 | P15848 | |
| IHGSAAMLYPMYWQH | 211 | Q8TEH3 | |
| MGAMLLVYLHQAGWF | 306 | Q9BSE4 | |
| WHPVLMVAGMVVFYG | 46 | Q8NBI2 | |
| HYKMFWFDHHGNSPM | 631 | Q8IZU8 | |
| MLHMLNGCHPWTQFF | 586 | Q99558 | |
| ALGGGYLHWGHFEMM | 91 | Q9NX20 | |
| MGHQQLYWSHPRKFG | 1 | P62273 | |
| SVGWMHAGYPIMCHL | 721 | Q9Y4C2 | |
| SAGWMHSGYPIMCHL | 721 | A6NFQ2 | |
| KAGHPFMWNQHLGYV | 266 | P06732 | |
| NAWLHMPMYFFLSHL | 51 | Q8NGP6 | |
| MNMKAVFGHPFSLGW | 266 | Q9NYG2 | |
| LGHAAMLGLMYVYWT | 581 | P04844 | |
| KLYWHGIGFLNHEMP | 211 | Q8TAQ9 | |
| VAMHLFGLNWHLQPM | 361 | Q6N022 | |
| SWEYLVHHVMAMGAF | 111 | Q96CP7 | |
| MWEVFTHGEMPHGGQ | 996 | Q13308 |